Francke, M. I. http://orcid.org/0000-0001-5641-8375
Visser, W. J.
Severs, D.
de Mik - van Egmond, A. M. E.
Hesselink, D. A.
De Winter, B. C. M.
Article History
Received: 16 December 2021
Accepted: 15 April 2022
First Online: 14 May 2022
Declarations
:
: D.A. Hesselink has received grant support (paid to his institution) from Astellas Pharma, Chiesi Farmaceutici SpA and Bristol Myers-Squibb, as well as lecture and consulting fees from Astellas Pharma, Chiesi Farmaceutici SpA, Novartis Pharma, and Vifor Pharma in the last 3 years. All other authors declared no competing interests for this work.